Travere Drug for Rare Kidney Condition Recommended for EU Approval

Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union's drug regulator for their drug Filspari, part of an industry...

Related Keywords

Ludwig Burger ,Mark Potter ,Vifor Pharma ,European Union ,Novartis ,European Commission ,Reuters ,Drug Administration For Filspari ,Travere Therapeutics ,Drug Administration ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Renal Impairment ,Europe ,European ,Kidneys ,Hemodialysis ,Vascular Access ,Kidney Dialysis ,Enal Dialysis Haemodialysis ,Iga Nephropathy ,Ga Nephritis ,Immunoglobulina Nephropathy ,Mmunoglobulina Nephritis ,Agan ,Erger Amp 039s Disease ,Ynpharyngitic Glomerulonephritis ,Biologic Therapy ,Iologics ,Transplantation Of An Organ ,